Loading clinical trials...

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT02078882

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis

The purpose of this study is to determine if abatacept (Orencia) is effective in patients with primary biliary cirrhosis who do not respond adequately to standard treatment with ursodeoxycholic acid (...

Lead sponsor: Christopher Bowlus, MD•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not RecruitingPhase 3

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

NCT04526665 · Primary Biliary Cirrhosis

Active Not RecruitingPhase 3

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

NCT03301506 · Primary Biliary Cirrhosis

COMPLETED

Repeatability and Reproducibility of Multiparametric MRI

NCT03743272 · Liver Diseases, Primary Biliary Cirrhosis, and more

COMPLETED

The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland

NCT02846896 · Primary Biliary Cirrhosis

COMPLETEDPhase 2

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

NCT03112681 · Primary Biliary Cirrhosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 9, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment16

Start dateSep 2014

Last updatedApr 9, 2020

Condition

Primary Biliary Cirrhosis

Locations shown

Univeristy of California Davis Medical Center

Sacramento, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions